Cite
A sample-to-answer COVID-19 diagnostic device based on immiscible filtration and CRISPR-Cas12a-assisted detection
MLA
Bongkot Ngamsom, et al. “A Sample-to-Answer COVID-19 Diagnostic Device Based on Immiscible Filtration and CRISPR-Cas12a-Assisted Detection.” Talanta Open, vol. 6, no. 100166-, Dec. 2022. EBSCOhost, https://doi.org/10.1016/j.talo.2022.100166.
APA
Bongkot Ngamsom, Alexander Iles, Moses Kamita, Racheal Kimani, Patrick Wakaba, Pablo Rodriguez-Mateos, Mary Mungai, Charlotte E. Dyer, Cheryl Walter, Jesse Gitaka, & Nicole Pamme. (2022). A sample-to-answer COVID-19 diagnostic device based on immiscible filtration and CRISPR-Cas12a-assisted detection. Talanta Open, 6(100166-). https://doi.org/10.1016/j.talo.2022.100166
Chicago
Bongkot Ngamsom, Alexander Iles, Moses Kamita, Racheal Kimani, Patrick Wakaba, Pablo Rodriguez-Mateos, Mary Mungai, et al. 2022. “A Sample-to-Answer COVID-19 Diagnostic Device Based on Immiscible Filtration and CRISPR-Cas12a-Assisted Detection.” Talanta Open 6 (100166-). doi:10.1016/j.talo.2022.100166.